Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DR26FKN2D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $12,467 delivery order to Amerisourcebergen Drug Corp on July 10, 2026, for SKYRIZI 360 mg/2.4 ml on-body injectables. The order is firm fixed-price with an ultimate completion date of July 31, 2026. Place of performance is Conshohocken, PA. The order was issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V indefinite delivery contract (SPE2DX), which supports worldwide military healthcare supply across multiple therapeutic domains for the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FKN2D?
SPE2DR26FKN2D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 10, 2026.
How much is contract SPE2DR26FKN2D worth?
The government has obligated $12,467 on SPE2DR26FKN2D.
Is contract SPE2DR26FKN2D an order under another contract?
Yes. SPE2DR26FKN2D is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FKN2D competed?
The extent of competition for SPE2DR26FKN2D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award